Education
About Us
Working with TipRanks
Follow Us
Rakovina Therapeutics Inc (TSE:RKV)
:RKV
RESEARCH TOOLSreports
RKV Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.35 - C$2.30
Previous CloseN/A
VolumeN/A
Average Volume (3M)37.63K
Market Cap
C$7.72M
Enterprise ValueC$12.90M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.69
Next Earnings
Nov 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding21,148,039
10 Day Avg. Volume36,030
30 Day Avg. Volume37,635
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Rakovina Therapeutics Inc News
RKV FAQ
What was Rakovina Therapeutics Inc’s price range in the past 12 months?
Rakovina Therapeutics Inc lowest stock price was C$0.34 and its highest was C$2.30 in the past 12 months.
What is Rakovina Therapeutics Inc’s market cap?
Rakovina Therapeutics Inc’s market cap is C$7.72M.
When is Rakovina Therapeutics Inc’s upcoming earnings report date?
Rakovina Therapeutics Inc’s upcoming earnings report date is Nov 27, 2025 which is in 73 days.
How were Rakovina Therapeutics Inc’s earnings last quarter?
Rakovina Therapeutics Inc released its earnings results on Aug 28, 2025. The company reported -C$0.18 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.18.
Is Rakovina Therapeutics Inc overvalued?
According to Wall Street analysts Rakovina Therapeutics Inc’s price is currently Overvalued.
Does Rakovina Therapeutics Inc pay dividends?
Rakovina Therapeutics Inc does not currently pay dividends.
What is Rakovina Therapeutics Inc’s EPS estimate?
Rakovina Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rakovina Therapeutics Inc have?
Rakovina Therapeutics Inc has 21,148,039 shares outstanding.
What happened to Rakovina Therapeutics Inc’s price movement after its last earnings report?
Rakovina Therapeutics Inc reported an EPS of -C$0.18 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6%.
Which hedge fund is a major shareholder of Rakovina Therapeutics Inc?
Currently, no hedge funds are holding shares in TSE:RKV
Company Description
Rakovina Therapeutics Inc
Vincero Capital Corp is a capital pool company. Its principal business is the identification and evaluation of assets or businesses, with a view to completing a qualifying transaction.
Technical Analysis
Aptose Biosciences
―
XORTX Therapeutics Inc
―
Quest Pharmatech
―
Appili Therapeutics Inc Class A
―
Marvel Biosciences Corp
―
Options Prices
Currently, No data available
---